Cardiology Grand Rounds from the University of North Carolina at Chapel Hill. The antioxidant vitamins and coronary heart disease: Part II. Randomized clinical trials.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 12544080)

Published in Am J Med Sci on January 01, 2003

Authors

Steven J Riley1, George A Stouffer

Author Affiliations

1: Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7075, USA.

Articles by these authors

Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era. Catheter Cardiovasc Interv (2002) 1.62

Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation (2003) 1.55

Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. J Clin Invest (2017) 1.38

The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation (2007) 1.34

Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling. Arterioscler Thromb Vasc Biol (2009) 1.23

A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J (2005) 1.12

Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function. Arterioscler Thromb Vasc Biol (2011) 1.11

Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. Atherosclerosis (2012) 1.07

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations. Pharmacogenomics (2009) 1.07

The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative. Am Heart J (2009) 1.04

A prospective randomized clinical trial of the use of fluoroscopy in obtaining femoral arterial access. J Invasive Cardiol (2009) 0.97

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients. Atherosclerosis (2013) 0.94

Tobacco use induces anti-apoptotic, proliferative patterns of gene expression in circulating leukocytes of Caucasian males. BMC Med Genomics (2008) 0.92

Acute ST-elevation myocardial infarction in patients hospitalized for noncardiac conditions. J Am Heart Assoc (2013) 0.91

Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers. Am J Cardiol (2011) 0.90

Stable patterns of gene expression regulating carbohydrate metabolism determined by geographic ancestry. PLoS One (2009) 0.90

Thermodilution and Fick cardiac outputs differ: impact on pulmonary hypertension evaluation. Can Respir J (2012) 0.86

The role of alpha(v)beta3 integrins in vascular healing. Thromb Haemost (2002) 0.85

Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions. Drugs (2011) 0.81

Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients. Pharmacogenomics (2015) 0.81

Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Intervention in Older Persons with Acute Coronary Syndrome-Part I. Clin Geriatr (2008) 0.80

beta(3)-Integrin cytoplasmic binding proteins. Arch Immunol Ther Exp (Warsz) (2004) 0.80

Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase. Catheter Cardiovasc Interv (2005) 0.79

Biventricular pulsus alternans. Cardiol Res Pract (2009) 0.79

Multivessel acute myocardial infarction: case report and review of the literature. Am J Med Sci (2008) 0.78

Relation of platelet count to bleeding and vascular complications in patients undergoing coronary angiography. Am J Cardiol (2010) 0.78

Is time of renal hypoperfusion an important variable in determining response to renal artery revascularization? JACC Cardiovasc Interv (2014) 0.77

Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2010) 0.77

Perivascular delivery of blebbistatin reduces neointimal hyperplasia after carotid injury in the mouse. J Pharmacol Exp Ther (2010) 0.76

Optimizing the use of thrombolytics in ST-segment elevation myocardial infarction. Drugs (2009) 0.76

In-stent restenosis: more fuel for the fire. Am Heart J (2002) 0.76

Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Intervention in Older Persons with Acute Coronary Syndrome-Part II. Clin Geriatr (2008) 0.76

Diagnosis and treatment of non-hemodynamically significant coronary heart disease: where to start? Trans Am Clin Climatol Assoc (2005) 0.75

Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells. Cardiovasc Diabetol (2008) 0.75

Vascular smooth muscle cell microparticles and coronary no-reflow: another piece of the puzzle? Thromb Haemost (2005) 0.75

Hemodynamic Findings of Severe Subacute Aortic Regurgitation. J Invasive Cardiol (2017) 0.75

Length of Stay, Mortality, Cost, and Perceptions of Care Associated With Transition From an Open to Closed Staffing Model in the Cardiac Intensive Care Unit. Crit Pathw Cardiol (2017) 0.75

Successful aspiration of Mynx vascular closure device sealant that embolized to the popliteal artery. J Invasive Cardiol (2013) 0.75

Cardiology Grand Rounds from The University of North Carolina at Chapel Hill. Contrast induced nephropathy after angiography. Am J Med Sci (2002) 0.75

Influence of sex on the accuracy of oscillometric-derived blood pressures. J Clin Hypertens (Greenwich) (2010) 0.75

Hemodynamics of myocardial bridging. Catheter Cardiovasc Interv (2008) 0.75

Cardiology Grand Rounds from the University of North Carolina at Chapel Hill. The antioxidant vitamins and coronary heart disease: Part 1. Basic science background and clinical observational studies. Am J Med Sci (2002) 0.75

Clopidogrel dose adjustment after outpatient screening for CYP2C19 variant alleles: a pilot study. Pharmacogenomics (2014) 0.75

Hemodynamics of renal artery stenosis. Catheter Cardiovasc Interv (2008) 0.75

Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndrome. Am J Cardiol (2006) 0.75

Hypertensive emergency in a young adult: diagnosis of FMD by renal angiography but not MRI/MRA. J Invasive Cardiol (2007) 0.75

Timing of surgery in aortic stenosis. Curr Treat Options Cardiovasc Med (2006) 0.75

The contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing. Angiology (2008) 0.75

Mechanical thrombectomy options in complex percutaneous coronary interventions. Catheter Cardiovasc Interv (2006) 0.75

Simultaneous occurrence of a single coronary artery and persistent left superior vena cava. Am J Med Sci (2011) 0.75

Risk of developing coronary artery disease following a normal coronary angiogram in middle-aged adults. J Invasive Cardiol (2014) 0.75

Review of clopidogrel dose escalation in the current era of potent P2Y12 inhibitors. Expert Rev Clin Pharmacol (2015) 0.75

Scintographic evidence of severe myocardial hypoperfusion in a patient with left anterior descending coronary artery bridging--case report and review of the literature. Am J Med Sci (2008) 0.75

Relation of pulse and systolic and mean blood pressure to severe renal artery stenosis in patients undergoing concurrent coronary and renal angiography. Am J Cardiol (2013) 0.75